The placenta in maternal hyperhomocysteinaemia

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 106, Issue 3, 1999, Pages 273-278

  Khong, T Y ^a   Hague, W M ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HEMATOMA; HUMAN; HYPERHOMOCYSTEINEMIA; INTRAUTERINE GROWTH RETARDATION; NEWBORN DISEASE; PLACENTA; PLACENTA DISORDER; PRIORITY JOURNAL; SOLUTIO PLACENTAE; THROMBOEMBOLISM; TROPHOBLAST;

ADOLESCENT; ADULT; FEMALE; HEMATOMA; HUMANS; HYPERHOMOCYSTEINEMIA; PLACENTA; PLACENTA DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; THROMBOSIS;

EID: 0033021552     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1999.tb08243.x     Document Type: Article

References (24)

1. Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Merubolic Basis of Inherited Disease: Vol 1 New York : McGraw-Hill, 1995: 1279–1327.
2. Clarke R, Daly L, Robinson K et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149–1155.
3. Engbersen AMT, Franken DG, Boers GHJ, Stevens EMB. Trijbels FJM. Blom HJ. Thermolabile 5.10 methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinaemia. Am J Hum Gener 1995;56: 142–150.
4. Goddijn-Wessel TAW, Wouters MGAJ, Vandermolen EF et al. Hyperhomocysteinemia-a risk factor for placental abruption or infarction. Eur J Obstet Gynecol Reprod Biol 1996; 66: 23–29.
5. Dekker GA, De Vries JIP, Doelitzch PM et al. Underlying disorders associated with severe early onset preeclampsia. Atn J Obstet Gynecol 1995; 173: 1042–1048.
6. Wouters MG, Boers GHJ, Blom HJ et al. Hyperhomocysteinemia-a risk factor in women with unexplained recurrent early pregnancy loss. Ferril Steril 1993; 60: 820–825.
7. den Heijer M, Koster T, Blom HI et al. Hyperhomocysteinemia as a risk factor for deepvein thrombosis. N Engl J Med 1996; 334: 759–762.
8. Australian Society for the Study of Hypertension in Pregnancy. Management of hypertension in pregnancy [Consensus Statement]. Sydney ASSHP, 1993.
9. Beeby PJ, Bhutap T, Taylor LK. New South Wales population- based birthweight percentile charts. J Paediatr Child Heulrh 1996;.
10. Leroy B, Lefort F, Neveu P, Risse RJ. Trevise P, Jeny R. Intrauterine growth charts for twin fetuses. Actu Genet Med Gemellol 1982: 31: 199–206.
11. Khong TY, Chambers HM. Alternative method for sampling placentas for the assessment of uteroplacental vasculature. J Clin Pathol 1992; 45: 925–927.
12. Pinar H, Sung CJ, Oyer CE, Singer DB. Reference values for singleton and twin placental weights. Pediatr Parhol Lab Med 1996; 16: 901–907.
13. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986; 93: 1049–1059.
14. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Assche A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obsret Gynaecol 1994; 101: 669–674.
15. Chambers JC, McGregor A, Jean-Marie J, Kooner JS. Acute hyperho-mocysteinaemia and endothelial dysfunction. Lancet 1998; 351: 36–37.
16. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomocyst (e)inemia is associated with impaired endothelium-dependent vasodilatationin humans. Circulation 1997; 95: 1119–1121.
17. Harpel PC, Zhang X, Borth W. Homocysteine and hemostasis: pathogenetic mechanisms predisposing to thrombosis. J Nutr 1996; 126: 1285 S–9 S.
18. Zini J-M, Murray SC, Graham CH et al. Characterization of urokinase receptor expression by human placental trophoblasts. Blood 1992; 79: 2917–2929.
19. Hofmann GE, Glatstein I, Schatz F, Heller D, Deligdisch L. Immuno-histochemical localization of urokinase-type plasminogen activator and the plasminogen activator inhibitors 1 and 2 in early human implantation sites. Am J Obster Gynecol 1994; 170: 671–676.
20. Calvert SM, Rand RJ. A successful pregnancy in a patient with homocystinuria and a previous near-fatal postpartum cavernous sinus thrombosis. Br J Obstet Gynaecol 1995; 102: 751–752.
21. Preston FE, Rosendaal FR, Walker ID et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996; 348: 913–916.
22. Rai R, Regan L, Hadley E, Dave M, Cohen H. Second-trimester pregnancy loss is associated with activated protein C resistance. Br J Haematol 1996; 92: 489–490.
23. Burke G, Robinson K, Refsum H, Stuart B, Drumm J, Graham I. Intrauterine growth retardation, perinatal death, and maternal homocysteine levels. N Engl J Med 1992; 326: 69–70.
24. Hibbard BM. Defective folate metabolism in pathological conditions of pregnancy. Acta Obsret Gynecol Scand 1967; 46 (Suppl 7): 47–59.